"We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions."

During the past decade, sanofi-aventis South Africa conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "sanofi-aventis South Africa" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator and "Procter and Gamble" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "sanofi-aventis South Africa" are "Acute Coronary Syndromes" (1 trials), "Asthma" (1 trials), "Breast Cancer" (1 trials), "Deep Venous Thrombosis" (1 trials) and "Head and Neck Neoplasms" (1 trials). Many other conditions were trialed in "sanofi-aventis South Africa" in a lesser frequency.

Most popular intervention types in "sanofi-aventis South Africa" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5-fluorouracil (5-FU)" (1 trials), "Avidin" (1 trials), "Ciclesonide" (1 trials) and "Clopidogrel (SR25990)" (1 trials). Other intervention names were less common.

The vast majority of trials in "sanofi-aventis South Africa" are 5 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "sanofi-aventis South Africa". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in sanofi-aventis South Africa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in sanofi-aventis South Africa, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".